Clinical trial for Anxiety
Official title Prediction of Anxiety and Memory State
ClinicalTrials.gov ID: NCT06551090
What this study is testing
- What it's testing
- The goal is to build a tool that uses brain and body signals to predict when a person is feeling anxious or having memory issues.
- Who it's for
- The study is looking for people with epilepsy who are staying in the hospital for brain monitoring.
- What's involved
- Participants will wear sensors and have brain electrodes placed to collect data on their brain activity, body signals, and behavior.
- Time commitment
- The study takes place during a hospital stay for epilepsy monitoring, which typically lasts several days.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Patients must have known or suspected Temporal Lobe Epilepsy.
- Native or proficient in speaking English or Spanish.
- Stereoelectroencephalography (sEEG) cases: The implant plan must include hippocampal head, body, and tail electrodes either unilaterally or...
- 7th grade reading level (minimum level considered literate for adults)
You likely can't join if
- Hearing impaired (i.e., not corrected with a hearing aid)
- Unable to read the newspaper at arm's length with corrective lenses.
- Objective intellectual impairment (estimated IQ \< 70)
- Any history of Electroconvulsive Therapy or psychosis (except postictal psychosis for patients)
- Psychotic disorder (lifetime)
- Current Anxiety disorder, Major Depressive Disorder, or Bipolar Disorder
See the full eligibility criteria
- Patients must have known or suspected Temporal Lobe Epilepsy.
- Native or proficient in speaking English or Spanish.
- Stereoelectroencephalography (sEEG) cases: The implant plan must include hippocampal head, body, and tail electrodes either unilaterally or bilaterally.
- 7th grade reading level (minimum level considered literate for adults)
- Hearing impaired (i.e., not corrected with a hearing aid)
- Unable to read the newspaper at arm's length with corrective lenses.
- Objective intellectual impairment (estimated IQ \< 70)
- Any history of Electroconvulsive Therapy or psychosis (except postictal psychosis for patients)
- Psychotic disorder (lifetime)
- Current Anxiety disorder, Major Depressive Disorder, or Bipolar Disorder
- Neurodegenerative diseases, presence of widespread brain lesions, language problems (other than naming difficulty)
- Medical conditions that could potentially affect cognitive performance (e.g., human immunodeficiency virus (HIV) infection, cancer with metastatic potential).
- Acute renal failure or end-stage renal disease
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.